Navigation Links
Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
Date:5/1/2013

rts on Form 10-Q.  The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.

Financial Exhibits Follow

 COVANCE INC.CONSOLIDATED INCOME STATEMENTSFOR THE THREE MONTHS ENDED MARCH 31, 2013 AND 2012(Dollars in thousands, except per share data)(UNAUDITED)Three Months Ended March 3120132012Net revenues$
580,199$
530,841Reimbursable out-of-pocket expenses54,13643,067Total revenues634,335573,908Costs and expenses:  Cost of revenue411,344376,460  Reimbursable out-of-pocket expenses54,13643,067  Selling, general and administrative89,21981,029  Depreciation and amortization31,38527,230Total costs and expenses586,084(a)527,786Income from operations48,251(a)46,122Other (income) expense, net:  Interest expense, net871493  Foreign exchange transaction loss, net335228  Gain on sale of investment(15,693)-Other (income) expense, net(14,487)(a)721Income before taxes and equity investee earnings62,738(a)45,401Taxes on income14,572(a)9,807Equity investee earnings -98Net income$
48,166(a)$
35,692Basic earnings per share$
.89(a)$
.62Weighted average shares outstanding - basic54,207,03257,745,855Diluted earnings per share$
.86(a)$
.60Weighted average shares outstanding - diluted56,307,03459,229,881(a) Three months ended March 31, 2013 includes, as applicable, $6,170 in restructuring costs ($4,347 net of tax), and $15,693 gain on sale of investment in BioClinica, Inc. ($10,194 net of tax).Excluding the impact of restructuring charges and gain on sale of investment, as applicable:Income from operations$
54,421$
46,122Taxes on income$
,896$
9,807Net income $
42,319$
35,692Basic earnings per share$
.78$
.62Diluted earnings per share$
.75$
.60 

 COVANCE INC.CONSOLIDATED BALANCE SHEETSMARCH 31, 2013 and DECEMBER 31, 2012(Dollars in thousands)March 31D
'/>"/>

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
5. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
7. Covance To Present At The Leerink Swann Global Healthcare Conference
8. Covance To Present At The Citi 2013 Global Healthcare Conference
9. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2013 Financial Results Conference Call
10. Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients Increased Asia Pacific Focus
11. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... DALLAS , Sept. 19, 2014 ... Market Outlook to 2020″, provides key ... General Surgery devices market. The report ... dollars, and volume (in units) within ... Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, ...
(Date:9/19/2014)... According to the new ... therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, ... Global Forecast to 2019" published by MarketsandMarkets, the global ... Million by 2019 from $14,240.0 Million in 2014, ... 2019. Browse 74 market data tables ...
(Date:9/19/2014)... , Sept. 19, 2014 Merck (NYSE: ... and Canada , is teaming with ... La Diabetes: Logra Tus Metas , an educational program encouraging Hispanics ... sugar -- a key treatment goal to help reduce the risk ... are at a higher risk for developing type 2 ...
Breaking Medicine Technology:United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
... Scientific Resources, Inc. (OTCQB: ASFX) ("American Scientific Resources" ... Products) Ltd. ("Syner-Med") is the Company,s new distributor ... for its non-contact thermometers. Syner-Med placed an initial ... retail and professional models, of the VeraTemp non-contact ...
... LIVINGSTON, N.J., March 14 , 2011 Milestone ... develops, manufactures, and markets computer-controlled injection systems for medical ... has commenced trading on the OTCQB(TM) electronic quotation and ... not required to take any action as a result ...
Cached Medicine Technology:American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland 2American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland 3Milestone Scientific Inc. Commences Trading on the OTC Pink 2
(Date:9/19/2014)... News) -- As kids transition from elementary to middle ... to a recent study. But the researchers ... that verbal and physical bullying declines as students get ... prevention strategies must address all types of bullying as ... the researchers said. The study was published recently in ...
(Date:9/19/2014)... 2014 Hastings and Hastings, a discount accident ... industry, announces a record number of visitors to its new ... of serious injury cases as well as auto accident cases ... related accident cases and others. Having served the state of ... the test of time when it comes to dedicated and ...
(Date:9/19/2014)... Rockville Centre, NY (PRWEB) September 19, 2014 ... 17, the manufacturers of the embattled blood-thinner Xarelto, named ... County Court of Common Pleas, have moved the court ... the cases do not have sufficient connection with Philadelphia.* ... & Development, et al. (No. 140304328; Pa. Comm. Pls., ...
(Date:9/19/2014)... News) -- Your brain structure could help predict how willing ... Researchers at Yale University found those with greater volume ... cortex may be more likely to engage in risky behavior ... The study, funded by the U.S. National Institute on Aging, ... in the Northeast. The researchers sought to determine how brain ...
(Date:9/19/2014)... (HealthDay News) -- The U.S. Food and Drug Administration approved ... is part of a class of once-a-week injectable drugs that ... diabetes. "Trulicity is a new treatment option, which ... to control blood sugar levels in the overall management of ... FDA,s Office of Drug Evaluation II, said in an agency ...
Breaking Medicine News(10 mins):Health News: Cyberbullying Seems to Ramp Up in Middle School 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3Health News:Brain Structure Might Help Predict Risky Behavior 2Health News:FDA Approves Another Weekly Injectable Drug for Type 2 Diabetes 2
... has estimated that nearly 55 percent of Americans, mostly ... of porous and brittle bones// that causes higher susceptibility ... has been found to contribute to lower bone mineral ... Katherine Tucker, PhD, director of the Epidemiology and Dietary ...
... (etanercept) safe to be used to treat psoriasis up to ... of the current studies were presented at the 15th European ... 'Biologic Medicine which means it is synthesized using recombinant DNA ... biotechnology. , , ,This biologic medicine acts by ...
... of daily physical exercise for their future good health, says ... 545 children at 36 nurseries in Glasgow. ,The ... of exercise - 30 minutes, three times a week, reported ... activity was not enough to affect the children's body mass ...
... its toll across India Thursday with over 40 people reported ... government maintained the situation did not merit an epidemic status. ... that of an epidemic and we expect that the number ... next two-three days. ,"So far we have recorded ...
... levels down for decades, ever since studies showed a strong ... years, experts have suggested that some people should aim even ... cholesterol called low-density lipoprotein for some high-risk people — even ... get there. ,Not so fast, says a team of ...
... some very interesting results following her study ... of alcoholics, which ultimately determine which drugs can be ... ,The urge to consume alcoholic drinks can be stifled ... by the researcher highlights which characteristics of a patient ...
Cached Medicine News:Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 2Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 3Health News:Enbrelr Enters Safer Zone After Recent Research 2Health News:India registers 3,000 dengue patients, toll crosses 40 2Health News:India registers 3,000 dengue patients, toll crosses 40 3Health News:India registers 3,000 dengue patients, toll crosses 40 4Health News:No Clear Evidence for Ultra-Low Cholesterol Targets? 2Health News:No Clear Evidence for Ultra-Low Cholesterol Targets? 3Health News:No Clear Evidence for Ultra-Low Cholesterol Targets? 4